Research output per year
Research output per year
Fingerprint
Dive into the research topics where Birgitte Bjørnhart is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 3 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Research output
-
Impact of comorbidity and venous thromboembolism on outcome in real-life non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibition (ICI)
Bjoernhart, B., Kristiansen, C., Hansen, K. H., Wedervang, K., Nyhus, C. H., Jorgensen, T. L., Herrstedt, J. & Schytte, T., 1. Dec 2020, In: Annals of Oncology. 31, Suppl. 7, p. S1437 1 p., 54P.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Open Access -
Real word experience with first-line immunotherapy in advanced non-small cell lung cancer patients in a Danish nationwide cohort
Mouritzen, M., Bjørnhart, B., Pøhl, M., Ladekarl, M., Vesteghem, C., Bøgsted, M., Moelby Nielsen, A. W., Meldgaard, P., Holmskov Hansen, K., Larsen, J. W. W., Kristiansen, C., Wedervang, K., Bareid-Oestby, A. C., Frank, M. S., Persson, G., Kirstensen, E. B., Hormann, P. H. & Carus, A., Sep 2020, In: Annals of Oncology. 31, Suppl. 4, 1334P.Research output: Contribution to journal › Conference abstract in journal › Research
-
The influence of polypharmacy on outcome in real life non-small cell lung cancer (NSCLC) patients treated with immunotherapy
Bjørnhart, B., Hansen, K. H., Jørgensen, T. L. & Herrstedt, J., 2020, In: Annals of Oncology. 31, Suppl. 4, 1333P.Research output: Contribution to journal › Conference abstract in journal › Research
-
Efficacy and safety of immune checkpoint inhibitors in a Danish real life non-small cell lung cancer population: a retrospective cohort study
Bjørnhart, B., Hansen, K. H., Jørgensen, T. L., Herrstedt, J. & Schytte, T., 3. Jul 2019, In: Acta Oncologica. 58, 7, p. 953-961Research output: Contribution to journal › Journal article › Research › peer-review
-
Efficacy and Safety of Immune Checkpoint Inhibitors in a Danish Real Life Non-Small Cell Lung Cancer Population
Bjornhart, B., Hansen, K., Jorgensen, T., Herrstedt, J. & Schytte, T., Oct 2019, In: Journal of Thoracic Oncology. 14, Suppl. 10, p. S979 1 p., EP1.04-22.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Press / Media
-
Nab-paclitaxel kan blive relevant alternativ for tidligere behandlet NSCLC
31/01/2021
1 Media contribution
Press/Media: Press / Media
-
Real World: Immun-checkpoint hæmmere har god effekt
11/09/2019
1 Media contribution
Press/Media: Press / Media